National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Search Our Work by NIH Institute/Center

Partnerships with this Institute

Key Initiatives, Research Partners

The Biomarkers Consortium

This groundbreaking initiative expands the science of targeted medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.

Programs in Development

Kidney Safety Biomarker Qualification

This kidney safety project will impact public health by generating the data needed to advance, among the scientific community, clinicians and regulators the acceptance of the new biomarkers that are appropriate for monitoring kidney safety in the clinic and from reaching alignment on how these biomarkers should be used to improve clinical diagnoses of drug-induced acute kidney injury (AKI) during drug development and during patient therapy with presently marketed and well known nephrotoxic drugs.

Completed Programs, Past Programs

Frequent Hemodialysis

To best benefit the hundreds of thousands of patients who rely upon life-sustaining kidney dialysis, this program supports the implementation of randomized clinical trials of daily in-center and home hemodialysis.

Program, Research Partners

Drug-Induced Liver Injury Network (DILIN)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) created the Drug-Induced Liver Injury Network to collect and carefully analyze cases of liver injury caused by prescription and non-prescription drugs, nutritional supplements and herbal remedies. 

Donate button

What is the National Institutes of Health?

The National Institutes of Health (NIH) is a part of the U.S. Department of Health and Human Services. Comprised of 27 institutes and centers, the NIH is the primary federal agency for conducting and supporting medical research.

NIH scientists investigate ways of treating, preventing, and even curing common and rare diseases. Learn more by visiting NIH's Web site.

Latest Press Releases
Foundation for the NIH Awards Lurie Prize to Ruslan M. Medzhitov for Groundbreaking Discoveries in the Immune System
FNIH And Geoffrey Beene Foundation Alzheimer’s Initiative Launch Innovation Challenge to Male/Female Differences in Alzheimer’s Disease
The Foundation for the NIH Biomarkers Consortium Begins Development of Patient-Reported Outcome Measures for Community-Acquired Pneumonia and Skin Infections
Foundation for the NIH Joins NIH In Seeking Proposals to Study Sports-Related Brain Injuries
Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
More »